Nickel as a Catalytic Driver of Necrotizing Enterocolitis

A decades-old disease with a missing variable

Necrotizing enterocolitis is one of the most devastating diseases of prematurity, and for decades it has been explained through the language of "dysbiosis," formula feeding, and opportunistic pathogens. Yet a central mechanistic question has persisted: why do the same microbial taxa repeatedly dominate in NEC, and what allows them to so effectively overwhelm the immature infant gut?

This work argues that the answer has been hiding in plain sight. By integrating microbiome data, microbial enzymology, nutritional immunology, and infant feeding practices, it reframes NEC not as a generic loss of microbial balance but as a specific, catalytically driven disease state organized around a single overlooked trace metal: nickel.

The core hypothesis: nickel as a catalytic driver

The pathogens consistently enriched in NEC — particularly Escherichia coli and related Enterobacteriaceae — depend on nickel-dependent enzymes to survive and outcompete commensals. Urease alkalinizes the local environment, [NiFe]-hydrogenases support anaerobic energy metabolism, and glyoxalase I detoxifies the reactive byproduct methylglyoxal generated under metabolic stress. Together these nickel metalloenzymes let pathogens neutralize acid, manage metabolic stress, evade neutrophil killing, and thrive under inflammatory conditions.

The central claim is that nickel is the rate-limiting cofactor for this virulence program. When nickel is scarce, these enzymes cannot be fully metalated and the pathways stay throttled; when nickel is abundant, the same pathways switch on. Under this model, nickel availability — not merely the presence of the organisms — determines whether the microbiome tips toward the pathogenic, NEC-associated state.

Nutritional immunity: the host tries to withhold nickel

Nutritional immunity is the host strategy of starving microbes of the metals they need. In the infant gut, defenses such as lactoferrin and calprotectin function to sequester and withhold metals, and the paper emphasizes that this withholding explicitly extends to nickel. These proteins are part of the innate effort to deny pathogens the cofactors that power enzymes like urease and glyoxalase I.

This framing sets up the central conflict of the disease. Host biology is actively working to keep nickel away from the microbes that would exploit it, which means anything that floods the gut with excess nickel directly opposes and overwhelms this protective metal-sequestration system.

The dietary paradox: breast milk versus formula

Human breast milk is naturally nickel-poor, consistent with a system evolved to keep this cofactor scarce. Infant formulas, however — and especially soy-based formulations — contain orders of magnitude higher nickel concentrations. In effect, formula can deliver a bolus of the exact metal required to activate microbial virulence pathways at precisely the moment the immature gut is most vulnerable.

The dietary insult compounds itself. Formula feeding is also associated with elevated gut pH and reduced colonization by acidifying commensals. Excess dietary nickel therefore does two things at once: it licenses pathogenic metabolism by supplying a limiting cofactor, and it undermines the host's nutritional-immunity strategy of keeping nickel out of microbial reach.

The metal–microbiome–disease pathway comes into focus

Viewed through this metallomic lens, the classic, well-replicated features of NEC stop looking like isolated observations. Reduced alpha diversity, Proteobacteria blooms, loss of protective taxa, epithelial injury, and inflammation become the predictable downstream consequences of a nickel-replete gut ecosystem in which nickel-dependent pathogens hold a decisive metabolic advantage.

The proposed causal chain runs from diet to metal to microbe to disease: nickel-rich formula plus higher gut pH raises nickel availability, which activates nickel-dependent enzymes in Enterobacteriaceae, which enables blooms of these taxa, which drive the epithelial injury and inflammation that clinicians recognize as NEC. The microbiology, the biochemistry, and the feeding data, the author argues, were already present — what was missing was the recognition that nickel ties them together.

Implications for prevention, diagnosis, and therapy

If nickel is a catalytic driver rather than an inert contaminant, several practical avenues follow. The framework has direct implications for infant formula composition (reducing nickel load, particularly in soy-based products), for NEC risk stratification based on dietary and gut-chemistry factors, and for biomarker development around nickel status and nickel-dependent enzyme activity.

It also motivates a class of nickel-targeted preventative and therapeutic strategies — approaches that limit nickel availability or inhibit nickel-dependent virulence enzymes — and calls on neonatology, microbiome science, metallomics, and nutrition to jointly test whether an overlooked trace metal has been quietly fueling the disease.

What this paper is — and is not

This is a synthesis and hypothesis paper, not a report of new experimental data. It integrates existing microbiome findings, established microbial enzymology, nutritional-immunology principles, and published infant-feeding data into a single unifying framework, then argues that this framework better explains the observed pattern of NEC than dysbiosis alone.

Because it is a mechanistic model, its value rests on being falsifiable: it makes concrete, testable predictions about nickel content of feeds, gut nickel availability, the activity of nickel-dependent enzymes, and the response of NEC-associated taxa. Readers should treat the nickel-driver hypothesis as a rigorous, evidence-informed argument that invites direct experimental testing — not as an already-proven clinical fact.